RT 20mg

RT is a synthetic multi-receptor peptide studied in laboratory research for its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor systems. It is classified as a triple receptor agonist in experimental models evaluating incretin and glucagon-related signaling pathways.

In controlled in vitro and preclinical research environments, RT is examined for receptor-binding dynamics, pathway selectivity, and downstream intracellular signaling mechanisms associated with metabolic and endocrine regulatory systems.

For laboratory, academic, or institutional research use only. Not for human or animal consumption.